今日吃瓜
Tag - chugai
Subscribe
Digital
Print
November 12, 2026
Subscribe
Digital
Print
Cyberattacks
Consumption tax
Foreign community in Japan
Latest News
Home Delivery
JAPAN
Politics
Society
Crime & Legal
Science & Health
Explainer
History
WORLD
Politics
Crime & Legal
Science & Health
Society
ASIA PACIFIC
Politics
Crime & Legal
Science & Health
Society
BUSINESS
Companies
Economy
Markets
Tech
SPORTS
Sumo
Soccer
Baseball
Basketball
Tennis
Olympics
More sports
OPINION
Editorials
Commentary
Geoeconomic Briefing
Environment
CLIMATE CHANGE
Energy
SUSTAINABILITY
WILDLIFE
EARTH SCIENCE
LIFE
Travel
Digital
Food & Drink
Style & Design
Language
Lifestyle
CULTURE
Film
Books
Music
Art
TV & Streaming
Stage
Entertainment news
COMMUNITY
Voices
Issues
How-tos
Our Lives
My Account
My Bookmarks
Logout
Subscribe for more access
CHUGAI
BUSINESS
/
Companies
Aug 8, 2025
Chugai stock drops the most since 1977 on disappointing obesity drug data
A study showed the drug, which it has licensed to Eli Lilly & Co., resulted in lower weight loss and higher rates of nausea and vomiting than anticipated.
BUSINESS
/
Companies
Apr 18, 2025
Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai
Eli Lilly’s orforglipron pill, licensed from Chugai Pharmaceutical, could reshape the booming weight-loss drug market, early data shows.
BUSINESS
/
WOMEN AT WORK
Dec 15, 2024
Forging a career through digital transformation and mindset change
Backed by a strong belief in career ownership, Satoko Shisai built her own success at IBM Japan and Chugai.
JAPAN
Mar 9, 2021
Drugmakers in Japan struggle to keep pace in COVID-19 medicine race
No applications for drugs specifically tailored to COVID-19 have been filed yet, as domestic pharmaceutical companies have not invested heavily enough in biomedicine.
BUSINESS
/
Markets
Jun 8, 2020
Chugai stock surges 60% to rival Sony’s value on hopes for virus treatment
Chugai Pharmaceutical is now 今日吃瓜 biggest drug company by market value after overtaking Daiichi Sankyo and Takeda Pharmaceutical.
BUSINESS
/
Companies
Aug 25, 2014
Roche said to have decided against bidding for rest of Chugai
Roche Holding AG decided against bidding for the almost 40 percent of drugmaker Chugai Pharmaceutical Co. that it doesn’t already own and is instead focused on its $8.3 billion acquisition of InterMune Inc., according to a person familiar with the matter.
WHAT’S TRENDING
Editors' Picks
Man arrested over operation of rogue cellular base station in Tokyo
Government betting on language app powered by anime and AI
Man arrested over theft of watch that was returned days later to Tokyo mall
Japan not immune to public backlash against data centers, experts say
Jensen Huang’s woes evoke sympathy and disbelief in his birthplace Taiwan
‘Godzilla Minus Zero’ makes monster debut at the box office
A toast to Naohiko Noguchi, sake’s first living national treasure
Few signs of thaw in Japan-China relations one year after Takaichi’s Taiwan remarks
Mariko Mori predicted the future. She’ll do it again.
A legend reborn: ‘Ocarina of Time’ remake improves on the Zelda masterpiece
Podcast
Kabukicho: Tokyo’s ‘stadium of desire’
Longform
Convenience stores, toilets and the allure of everyday Japan
By
Elizabeth Beattie
SUSTAINABLE JAPAN
SPECIAL SUPPLEMENTS
Sponsored contents planned and edited by JT Media Enterprise Division.
SUPPLEMENTS BINDER